Renaissance Technologies - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 218 filers reported holding ACCELERON PHARMA INC in Q1 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q4 2020$4,759,000
-79.4%
37,200
-81.9%
0.01%
-78.3%
Q3 2020$23,092,000
+78.7%
205,207
+51.3%
0.02%
+109.1%
Q2 2020$12,919,000
-28.0%
135,600
-32.1%
0.01%
-35.3%
Q1 2020$17,938,000
+760.3%
199,600
+246.5%
0.02%
+325.0%
Q3 2016$2,085,000
+2.5%
57,600
-10.4%
0.00%
-20.0%
Q2 2015$2,034,00064,3000.01%
Other shareholders
ACCELERON PHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Polaris Venture Management Co IV LLC 3,133,234$124,076,00082.43%
Deer VII & Co. Ltd. 1,105,964$39,417,0009.51%
Foresite Capital Management I, LLC 66,000$2,614,0002.54%
QVT Financial LP 556,574$21,592,0001.27%
Orbimed Advisors 2,117,648$83,859,0001.23%
SPHERA FUNDS MANAGEMENT LTD. 50,000$1,980,0000.55%
WALL STREET ASSOCIATES 93,800$3,714,0000.30%
DRIEHAUS CAPITAL MANAGEMENT LLC 197,219$7,810,0000.28%
EAM Investors, LLC 37,871$1,500,0000.27%
Granite Point Capital Management, L.P. 30,000$1,188,0000.20%
View complete list of ACCELERON PHARMA INC shareholders